Efficacy of Atorvastatin Against Venous Thromboembolism After Total Hip Arthroplasty
- PMID: 40452196
- PMCID: PMC12131077
- DOI: 10.22540/JMNI-25-201
Efficacy of Atorvastatin Against Venous Thromboembolism After Total Hip Arthroplasty
Abstract
Objective: We examined the effect of atorvastatin on the prevention and management of venous thromboembolism (VTE) after total hip arthroplasty (THA).
Methods: A total of 300 patients were equally assigned to a treatment group and a control group. The treatment group received oral atorvastatin calcium tablets (20 mg/day) starting on the first day after surgery. The incidence of deep vein thrombosis, pulmonary embolism, incision hemorrhage, postoperative infection, and incision ecchymosis were evaluated in both groups. Additionally, hemoglobin levels, hematocrit, visual analog scale (VAS) pain scores, Harris hip scores, and Harris grading were compared between the two groups.
Results: The incidence of deep vein thrombosis, pulmonary embolism, incision hemorrhage, postoperative infection, and incision ecchymosis was significantly lower in the treatment group after atorvastatin intervention (P < 0.05 vs. control group). The hemoglobin levels, hematocrits, and VAS scores in the treatment group were significantly lower on days 1, 3, 7, and 14 after surgery (P < 0.05 vs. control group). The Harris hip scores and the number of patients with excellent Harris grading were significantly higher in the treatment group (P < 0.05 vs. control group).
Conclusion: Atorvastatin is effective in preventing VTE after THA and in improving postoperative joint function.
Keywords: Atorvastatin; Total Hip Arthroplasty; Venous Thromboembolism.
Conflict of interest statement
The authors have no conflict of interest.
Similar articles
-
[Comparison of muscle injury between piriformis muscle release and preservation in total hip arthroplasty via supercapsular percutaneously-assisted total hip approach].Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2025 Jun 15;39(6):715-722. doi: 10.7507/1002-1892.202502039. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2025. PMID: 40545460 Free PMC article. Clinical Trial. Chinese.
-
Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair.Cochrane Database Syst Rev. 2016 Mar 30;3(3):CD004179. doi: 10.1002/14651858.CD004179.pub2. Cochrane Database Syst Rev. 2016. PMID: 27027384 Free PMC article.
-
Different types of intermittent pneumatic compression devices for preventing venous thromboembolism in patients after total hip replacement.Cochrane Database Syst Rev. 2012 Nov 14;11:CD009543. doi: 10.1002/14651858.CD009543.pub2. Cochrane Database Syst Rev. 2012. Update in: Cochrane Database Syst Rev. 2014 Dec 22;(12):CD009543. doi: 10.1002/14651858.CD009543.pub3. PMID: 23152279 Updated.
-
High Risk of Venous Thromboembolism With Aspirin Prophylaxis After THA for High-riding Developmental Dysplasia of the Hip: A Retrospective, Comparative Study.Clin Orthop Relat Res. 2025 Jun 9. doi: 10.1097/CORR.0000000000003482. Online ahead of print. Clin Orthop Relat Res. 2025. PMID: 40536765
-
Pharmacological interventions for preventing venous thromboembolism in people undergoing bariatric surgery.Cochrane Database Syst Rev. 2022 Nov 22;11(11):CD013683. doi: 10.1002/14651858.CD013683.pub2. Cochrane Database Syst Rev. 2022. PMID: 36413425 Free PMC article.
References
-
- Lieberman JR, Bell JA. Venous Thromboembolic Prophylaxis After Total Hip and Knee Arthroplasty. J Bone Joint Surg Am. 2021;103:1556–64. - PubMed
-
- Zhang Y, Qian Q, Qian G, Sun G. Laboratory monitoring of rivaroxaban and assessment of its bleeding risk. Br J Biomed Sci. 2016;73:134–9. - PubMed
-
- Sorensen HT, Horvath-Puho E, Sogaard KK, et al. Arterial cardiovascular events, statins, low-dose aspirin and subsequent risk of venous thromboembolism:a population-based case-control study. J Thromb Haemost. 2009;7:521–8. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical